Astera Labs Inc (ALAB) concluded trading on Wednesday at a closing price of $71.09, with 8.73 million shares of worth about $620.37 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.15% during that period and on May 07, 2025 the price saw a loss of about -0.38%. Currently the company’s common shares owned by public are about 164.91M shares, out of which, 124.00M shares are available for trading.
Stock saw a price change of 8.85% in past 5 days and over the past one month there was a price change of 28.88%. Year-to-date (YTD), ALAB shares are showing a performance of -46.33% which decreased to -7.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $147.39 during that period. The average intraday trading volume for Astera Labs Inc shares is 4.57 million. The stock is currently trading 11.67% above its 20-day simple moving average (SMA20), while that difference is up 8.82% for SMA50 and it goes to -7.57% lower than SMA200.
Astera Labs Inc (NASDAQ: ALAB) currently have 164.91M outstanding shares and institutions hold larger chunk of about 54.28% of that.
The stock has a current market capitalization of $11.72B and its 3Y-monthly beta is at 0.34. PE ratio of stock for trailing 12 months is 303.03, while it has posted earnings per share of $0.23 in the same period. Its PEG reads 7.12 and has Quick Ratio of 13.26 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 5.64% while standing at 7.32% over the month.
Stock’s fiscal year EPS is expected to rise by 60.13% while it is estimated to increase by 27.53% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on March 14, 2025 offering an Outperform rating for the stock and assigned a target price of $82 to it. Coverage by Northland Capital stated Astera Labs Inc (ALAB) stock as an Outperform in their note to investors on January 28, 2025, suggesting a price target of $120 for the stock. On January 21, 2025, Morgan Stanley Downgrade their recommendations, while on January 02, 2025, Northland Capital Downgrade their ratings for the stock with a price target of $120. Stock get a Buy rating from Citigroup on November 18, 2024.
